← Research library

Cerluten: clinical report on a tissue-derived preparation

Comparison in people · 2006

What was studied
85 patients: 48 adjunctive Cerluten; 37 conventional-care controls. Mixed neurological diagnoses.
Main finding
The 2005–2006 report describes attention-test and selected EEG improvements during 10–20 days of adjunctive treatment.

Study data at a glance

Participants or experimental model
85 patients: 48 adjunctive Cerluten; 37 conventional-care controls. Mixed neurological diagnoses.
Reported results
The 2005–2006 report describes attention-test and selected EEG improvements during 10–20 days of adjunctive treatment.
Study limitations and source details

Study limitations

  • Random allocation and blinding are not documented. EEG assessment selected more severely affected patients; the findings cannot establish stroke recovery or benefit in healthy people.
  • Commercially reproduced institute report; independent peer review and independent replication are not established by this document.
  • Short-term reporting without a complete adverse-event protocol cannot establish long-term safety. Preparation equivalence to current products or synthetic peptides is unproven.

Source details

Institute report — commercial reproduction

Russian report reproduced on a commercial website; population, comparison and reported outcomes checked. Signed original and full protocol not authenticated.

Sources checked

Citation

Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology

Human comparative studyRussian-language source

St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution). Cerluten: clinical report on a tissue-derived preparation Institute clinical report (commercial reproduction); 2006 study/report date, not website publication date

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards